Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The trial aims to study the use of probiotics in preventing hepatocellular carcinoma in patients with cirrhosis. The trial involves the administration of specific probiotic strains and has inclusion and exclusion criteria related to the diagnosis of cirrhosis and hepatocellular carcinoma.
Primary outcome measures
Number of patients developing Hepatocellular carcinoma
Published data not found…